Condition
Thyroid Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 12 Thyroid Carcinoma clinical trials that are recruiting, at sites in 10 countries (most in China (5), Italy (5), United States (4)). By phase: Phase 1/2 (1), Phase 1 (1). There are also 5 NIH-funded research projects on Thyroid Carcinoma, with $2.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12Clinical trials
- 5NIH research projects
- 10Countries
Newest Thyroid Carcinoma clinical trials
All recruiting trials (12)
-
Thyroid cancer risk and follow-up after childhood radiotherapy
This project will test whether earlier and regular ultrasound plus genetic testing can detect thyroid nodules and cancers sooner in children treated with radiotherapy.
-
Laryngopharyngeal injuries after breathing tube placement during general anesthesia
This project sees how often and why people who had a breathing tube during general anesthesia developed hoarseness or other throat problems after non-ear–nose–throat surgery.
-
Nanosecond pulsed field ablation for small papillary thyroid cancer
This will test whether ultrasound-guided nanosecond pulsed field ablation can shrink or remove small (≤1.5 cm) papillary thyroid cancers in patients without spread.
-
International registry for very rare childhood tumors
This project will collect detailed medical information to see how clinical and biological features affect outcomes in children and adolescents with very rare tumors.
-
Electrical stimulation after thyroid surgery to help with pain
This trial tests whether a non-drug electrical stimulation method (TENS-WAA) can reduce pain after thyroid surgery compared with a sham treatment.
-
Evaluating blood biomarkers in advanced thyroid cancer
This study is testing if analyzing blood samples from adults with advanced thyroid cancer can help doctors choose better treatments and track how well they work.
-
Evaluating diagnostic and therapeutic strategies for thyroid conditions
This study is testing different ways to diagnose and treat thyroid problems, like hypothyroidism and thyroid cancer, to see which methods work best for patients.
-
Contrast-enhanced ultrasound to improve scoring for thyroid cancer diagnosis
This project will test whether adding contrast-enhanced ultrasound to gray-scale ultrasound helps doctors better tell which thyroid nodules are cancerous for patients who have had biopsies.
-
Evaluating BDTX-4933 for patients with specific cancer mutations
This study is testing a new drug called BDTX-4933 to see if it can help adults with advanced cancers that have certain gene mutations feel better and improve their treatment options.
-
Evaluating neck anatomy function during thyroid surgery
This study is testing if using heat treatment during thyroid surgery can help patients with low-risk thyroid cancer and benign nodules avoid having their entire thyroid removed.
-
Using Iodine-124 PET scans to assess metastatic thyroid cancer treatment
This study is testing a new type of PET scan using iodine-124 to see how well it can help doctors decide on the best treatment for people with metastatic thyroid cancer.
-
Registry for rare lung tumors and DICER1-related conditions
This study is collecting information about rare lung tumors in children, like pleuropulmonary blastoma, to help doctors understand how these conditions develop and how to treat them better.
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
How support cells (fibroblasts) affect thyroid cancer growth
This research looks at whether certain support cells called cancer-associated fibroblasts, marked by FAP and Wnt signals, help some thyroid cancers become more aggressive so tests or treatments can be developed.
-
Investigating how cancer-associated fibroblasts affect thyroid cancer.
This study is looking at how certain cells in the thyroid can affect the growth of thyroid cancer, with the hope of finding new ways to improve treatment for patients like you.
-
Investigating how certain cells in thyroid cancer affect disease progression
This study is looking at how certain cells in the thyroid, called cancer-associated fibroblasts, help aggressive thyroid cancers grow and spread, with the hope of finding new ways to predict and improve treatment for patients with these tough-to-treat cancers.
-
Investigating how Wnt signaling affects aggressive thyroid cancer
This study is looking at how certain signals in the body affect aggressive thyroid cancers that come back after treatment, and it aims to find new ways to help patients by testing how these cancers respond to specific drugs.
-
Investigating a new RNA's role in aggressive thyroid cancer
This study is looking at a tough type of thyroid cancer called BRAFV600E-papillary thyroid carcinoma to see how a newly discovered RNA affects how the cancer uses iodine and survives, with the goal of finding better treatment options for patients like you.
Related topics
Quick answers
How many Thyroid Carcinoma clinical trials are recruiting right now?
12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in China (5 trials), Italy (5 trials), United States (4 trials), Australia (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.